Abstract-Treatment of human serum albumin with a proteolytic enzyme such as pepsin, a-chymotrypsin, cathepsin D or trypsin generated histamine releasing peptides.
Abstract-Treatment of human serum albumin with a proteolytic enzyme such as pepsin, a-chymotrypsin, cathepsin D or trypsin generated histamine releasing peptides.
A low-molecular weight peptide (P-1) responsible for releasing hista mine was isolated from peptic digests of human serum albumin by affinity chromato graphy on heparin-Ultrogel and reversed-phase high performance liquid chromato graphy.
The amino acid sequence of the P-1 was estimated to be V-R-Y-T-K-K V-P-Q-V-S-T-P-T-L by Edman degradation.
The sequence determined appears to correspond to residues 409-423 of human serum albumin. Peptide P-1 pro duced dose-related histamine release from isolated rat mast cells in the concentration range of 1-50 ,cM. The intradermal injection of the P-1 (0.5 ug) increased capillary permeability in rats. This response was blocked by the antihistamine diphen hydramine.
The mast cell plays an important role in allergy and inflammatory reactions by re leasing biologically active substances in cluding histamine and enzymes which are located in the cellular granules. The activa tion of mast cells has been extensively studied using various immunologic or nonimmuologic stimulants (1). Mast cell activation is also induced by numerous polypeptides such as anaphylatoxins C3a and C5a (2), kinins (3), IgE-derived polypeptides (4), neurotensin (5, 6) and dynorphin (7). Recently, we purified and characterized peptides with histamine releasing activity from human parotid saliva (8, 9). During this study, we found that histamine release from mast cells was induced by proteolytic digests of various serum albumins. We report here the isolation of a histamine releasing peptide, P-1, obtained after pepsin treatment of human serum al bumin (HSA) and the determination of the amino acid sequence of the peptide P-1.
Materials and Methods
Mast cells and histamine release: Mast cells were purified on a Percoll gradient (10) from the peritoneal fluids of male Wistar rats (300-350 g). The purity of the mast cells used was more than 90%. The cells were suspended in a phosphate-buffered saline (PBS; 154 mM NaCI, 2.7 mM KCI, 0.9 mM CaCl2, 6.7 mM KH2PO4-Na2HP04, pH 7.2, and 0.01% bovine serum albumin). For his tamine release, the mast cells (105 cells/ml) suspended in 0.5 ml PBS were incubated with enzymic digests for 10 min at 37'C, and the reaction was terminated by adding 1.5 ml of ice-cold PBS. The reaction tubes were centrifuged at 3000 x g for 15 min at 4'C. The histamine concentration in the supernatants and precipitates were determined fluorome trically (11). Release of histamine was ex pressed as a percent release of the total cell content. and 50 mM Tris-HCI buffer (pH 7.5) for thrombin and plasmin by using enzyme/HSA ratios of 1:100, w/w, respectively.
Chromatography: Affinity chromatography was performed using a column of heparin Ultrogel (15x80 mm, LKB) equilibrated with 10 mM Tris-HCI (pH 7.5). High performance liquid chromatography (HPLC) was carried out using a Toso system with an analytical (4.6x250 mm) or semipreparative column (7.8X300 mm) of TSKgeI ODS-120T. High pressure gel permeation chromatography was performed using a TSKgel-2000 GW column (7.5 X 300 mm).
Amino acid and sequence determination: P-1 was hydrolyzed in vacuo in 6 N HCI at 110°C for 24 hr. Analysis was carried out with a Hitachi 835 automated analyzer. The C terminal residue was determined by treatment of the peptide with carboxypeptidase A (13). The amino acid sequence was determined by automated Edman degradation with an applied biosystem gas-phase model 470A automatic sequencer (14). Phenylthiohydan toin derivatives of amino acids were iden tified by HPLC (15 of a-chymo trypsin and thrombin itself (more than 100 ug/ ml) released histamine. Figure 2 shows the time course of peptic digestion of HSA and appearance of histamine releasing activity. The histamine releasing activity appeared after 5 min of incubation with pepsin at pH 2.5 and reached a maximum after 30 min. However, HSA without pepsin and pepsin itself had no activity in stimulating the release of histamine.
The digests obtained at different time in tervals were analyzed by gel filtration on a TSKgeI 2000 GM column (Fig. 3) . HSA showed two peaks corresponding to the monomer and dimer before addition of pepsin. Digestion of HSA was detectable after 1 min, and there was no change in the chromatographic patterns after 30 min of digestion. The degranulating activites were found in the fractions with molecular weights lower than 18 kilodaltons after 60 min of digestion. Table 1 shows histamine release by pep tic digests of various proteins. The peptic digests of bovine and rat serum albumin, and human IgG had histamine releasing activity comparable to the activity of HSA, but no activity was found in the digest of egg al bumin. Fig. 3 . High pressure gel permeation chromato graphy of digests of HSA. Digestions of HSA were carried out at pH 2.5 in the presence of pepsin as described in Fig. 2 . For the separation, the buffer was 50 mM sodium phosphate (pH 7.0) with 300 mM NaCI. Molecular weight markers included pepsin (34.7 KD), (3-lactoglobulin (18KD) and myoglobin fragment 1 (8KD). Aliquots of the eluates of 60-min digests of HSA were assayed for degranulation. Isolation of P-1 peptide: When pepsin treated HSA was subjected to affinity chroma tography on a heparin-Ultrogel column, ap proximately 30% of the initial preparation had adsorbed to the gel. After extensive washing of the column with the equilibration buffer, elution was performed with a stepwise gradient of NaCI in the same buffer. As shown in Fig. 4A , two peaks were obtained. The fraction P-1 that was eluted with 0.2 M NaCl in 10 mM Tris-HCI buffer (pH 7.5) had the highest specific activity. After lyophilization, the P-1 fraction was further purified by re versed-phase H PLC. Figure 4B shows that HPLC gave a single peak with histamine releasing activity. The yield of purified P-1 was about 6 mg/g of HSA. Peptic digest (corresponding to 250 mg HSA) was applied on a heparin-Ultrogel column (20x80 mm) equilibrated with 10 mM Tris-HCI buffer (pH 7.5). Elution was carried out in a stepwise gradient of NaCI as indicated.
Fractions of .5 ml each were collected, and 25-pl aliquots were assayed for mast-cell degranulation.
(B): HPLC. A sample was loaded on a TSKgel ODS-120T column equilibrated with a linear gradient from solvent A (10% acetonitrile containing 0.05% trif!uoroacetic acid (TFA)) to solvent B (50% acetonitrile containing 0.05% TFA) for 40 min at a flow rate of 1 ml/min. Hatched area represents histamine releasing activity. Amino acid composition and sequence of peptide P-1: Amino-acid analysis revealed that purified P-1 consisted of 15 amino acids: Val 3, Arg 1, Tyr 1, Lys 2, Pro 2, Glu 1, Ser 1, Thr 3 and Leu 1. The C-terminal residue of P-1 was determined to be leucine by treat ment with carboxypeptidase A. The N terminal residues of P-1 were identical at 15 cycles of automated Edman degradation. From these results, the sequence of P-1 was deduced to be Val-Arg-Tyr-Thr-Lys-Lys-Val Pro-Gln-Val-Ser-Thr-Pro-Thr-Leu.
This se quence was found to be identical with that of HSA residues 409 through 423 determined by Brown (16) . The molecular weight of P-1 calculated from the amino acid sequence was 1,717.
Histamine release by purified P-1: Figure 5 shows histamine release induced by the purified P-1 from isolated rat mast cells. The histamine release was detectable at 10-6 M and increased as the concentration of P-1 was raised, showing a plateau at 5x10-5 M. When the P-1 was injected intradermally into rat skin, the vascular permeability increased as shown in Fig. 6 . The simultaneous injec tion of the antihistamine diphenhydramine abolished the response produced by the P-1 and histamine itself. Fig. 6 . The effect of peptide P-1 on vascular permeability in rat skin and its prevention by anti histamine. The black areas show the leakage of Evans blue. Site 1 : saline, sites 2, 3 and 4: P-1 (0.5, 1.0 and 10 ,ag, respectively) and site 5: histamine (1 pg). Sites 6, 7, 8, 9 and 10: injected with mixtures of 1 pg diphenhydramine hydrochloride and saline, 0.5 gg P-1, 1.0 ,ug P-1, 10 pg P-1 and 1 erg histamine, respectively.
Discussion
The results presented here demonstrate that the polypeptides responsible for his tamine release from mast cells are produced by proteolytic digestion of several mammalian serum albumins. From a peptic digest of HSA, we isolated a histamine releasing peptide, P-1, that has an affinity for heparin. The P-1 was found to be a basic pentadecapeptide with a molecular weight of 1,717.
It is well-known that histamine releasing peptides can be generated by proteolysis of serum components such as IgG (17) , com plement (18) and a2-globulin (19) . Recently, Carraway et al. (20) reported that pepsin liberated a neurotensin-related peptide (NRP) from HSA, and the NRP had the ability to release histamine from rat mast cells. They also showed that the sequence of NRP was very similar to that of amino acid residues 137-149 of the HSA molecule. However, the substrate of NRP was not a normal albumin but an isoalbumin (21) . On the other hand, the peptide P-1 isolated as above was com pletely identical with the sequence of normal HSA residues 409 through 423 determined by Brown (16) . Therefore, the peptide P-1 was different from NRP, although a variety of peptides responsible for histamine release were produced by peptic digestion of HSA as shown in Fig. 3 . Serum albumin is a factor which con tributes to the osmotic pressure of the blood and is also known to bind a wide variety of ligands including fatty acids, bilirubin, amino acids, hormones and drugs (22). The region that the P-1 occupies is involved in the binding of long-chain fatty acid in the HSA molecule (23) . It is interesting to estimate whether the binding ability for fatty acid is related to the stimulation of the histamine release from mast cells, and studies are in progress on this aspect.
It has been reported that HSA is cleaved by limited peptic digestion to fragments corres ponding to residues 1-307, 308-422, 308 584 and 423-584 in the HSA sequence (24, 25) . The peptide P-1 appears to be produced by more elaborate cleavage of fragment 308 584. However, there is no literature to refer to about the peptide P-1 and its biological activity.
Numerous basic polypeptides incuding a number of physiologically active substances cause histamine release from mast cells (1, 3, 4, 5). These peptides induce noncytotoxic release, but the mechanisms of action are unclear in detail. Foreman et al. (26) have described that the basic amino acids at the N-terminus and the hydrophobic amino acids in the C-terminus are required as essential structures for the histamine-releasing pep tides. The peptide P-1 contains three basic amino acids such as arginine and lysine in its peptide structure. These basic amino acids are also located in its N-terminus. Thus, positively charged residues may be necessary for interaction with some receptor site of the mast cell.
Our results also show that the increase in vascular permeability in rat skin was caused by the injection of P-1, and this response was completely blocked by an antihistamine (Fig.  6 ). This result indicates that P-1 causes an increase in cutaneous vascular permeability by releasing histamine from the skin mast cells, because P-1 caused the release of his tamine from isolated rat mast cells (Fig. 5) . The physiological meaning of this peptide is unclear at present. The histamine-releasing peptides which are generated from serum albumin might play a role in the inflammatory response, since these peptides are produced not only by acidic enzymes but also by neutral enzymes (Fig. 1 ) .
